Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-990 Cr₹-856 Cr₹-288 Cr₹122 Cr₹122 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA is ₹-990 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-990 Cr
Mar2024₹-856 Cr
Mar2023₹-288 Cr
Mar2022₹122 Cr
Mar2021₹122 Cr

How is Deferred Tax Assets / Liabilities of AUROBINDO PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-990 Cr
Negative
Mar2024 ₹-856 Cr
Negative
Mar2023 ₹-288 Cr
Negative
Mar2022 ₹122 Cr
0.40
Mar2021 ₹122 Cr -

Compare Deferred Tax Assets / Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹69,768.6 Cr -2% -0.5% 5.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,991.0 Cr 0.1% -3.2% -2.6% Stock Analytics
DIVIS LABORATORIES ₹162,371.0 Cr -1.5% -7.3% 2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,229.0 Cr -1.3% -0.7% 24.4% Stock Analytics
CIPLA ₹108,441.0 Cr 1.5% -8.1% -6.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,407.0 Cr 3.2% 5.6% 3.1% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-2%

-0.5%

5.7%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses